Core Laboratories, Inc. (CLB) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

334.32 k

Shareholding (Jun 2025)

FII

9.38%

Held by 78 FIIs

DII

33.83%

Held by 65 DIIs

Promoter

0.00%

How big is Core Laboratories, Inc.?

22-Jun-2025

As of Jun 18, Core Laboratories, Inc. has a market capitalization of 595.53 million, with net sales of 517.81 million and a net profit of 28.73 million over the latest four quarters. Shareholder's funds are 251.99 million, and total assets amount to 590.41 million.

What does Core Laboratories, Inc. do?

22-Jun-2025

Core Laboratories, Inc. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry. As of March 2025, it has a market cap of $595.53 million, with net sales of $124 million and a P/E ratio of 21.00.

Who are in the management team of Core Laboratories, Inc.?

22-Jun-2025

As of March 2022, the management team of Core Laboratories, Inc. includes Lawrence Bruno as Chairman and CEO, with Martha Carnes as Proposed Independent Lead Director, and independent board members Gregory Barnett, Harvey Klingensmith, Michael Straughen, and Monique Van Dijken Eeuwijk.

Is Core Laboratories, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Core Laboratories, Inc. shows a mildly bullish trend supported by positive MACD and Bollinger Bands indicators, despite some short-term caution from daily moving averages.

Is Core Laboratories, Inc. overvalued or undervalued?

25-Nov-2025

As of November 21, 2025, Core Laboratories, Inc. is considered very expensive and overvalued with a P/E ratio of 21 and underperformed the S&P 500, showing a year-to-date return of -14.85% compared to the index's 12.26%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Positive results in Jun 25

OPERATING CASH FLOW(Y) Highest at USD 54.4 MM
DEBT-EQUITY RATIO (HY) Lowest at 56.4 %

With ROCE of 12.51%, it has a very expensive valuation with a 1.74 Enterprise value to Capital Employed

High Institutional Holdings at 100%

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Oil

Market cap

USD 584 Million (Micro Cap)

P/E

21.00

Industry P/E

Dividend Yield

63.91%

Debt Equity

0.40

Return on Equity

9.84%

Price to Book

2.24

Revenue and Profits:

Net Sales:

130 Million

(Quarterly Results - Jun 2025)

Net Profit:

11 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

32.13%

6 Months

48.69%

1 Year

-18.24%

2 Years

-9.15%

3 Years

-24.94%

4 Years

-29.8%

5 Years

-38.17%

Core Laboratories, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Core Laboratories, Inc. overvalued or undervalued?

As of 21 November 2025, the valuation grade for Core Laboratories, Inc. moved from expensive to very expensive, indicating a significant shift in its perceived value. The company appears overvalued, with a P/E ratio of 21, which is higher than the peer average of 22.72, and an EV to EBITDA ratio of 10.54, compared to its peer average of 11.61. Additionally, the Price to Book Value stands at 2.08, suggesting that the stock is trading at a premium relative to its book value. In terms of peer comparison, while Core Laboratories has a lower EV to EBITDA than its peer average, its overall valuation metrics indicate that it is not aligned with the market's expectations for growth and profitability. The stock has underperformed significantly against the S&P 500, with a YTD return of -14.96% compared to the index's 12.26%, and a 3-year return of -28.27% versus 67.17% for the S&P 500, reinforcing the notion that th...

Is Core Laboratories, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Core Laboratories, Inc. has changed from mildly bearish to mildly bullish. The weekly and monthly MACD indicators are both mildly bullish, supporting the positive shift in trend. Bollinger Bands are also bullish on both time frames, indicating potential upward momentum. However, the daily moving averages remain mildly bearish, suggesting some short-term caution. The KST shows a bullish weekly signal but is bearish on the monthly, while the Dow Theory and OBV are both mildly bullish across weekly and monthly periods. Overall, the technical stance is mildly bullish, driven primarily by the MACD and Bollinger Bands. Multi-period return data is not available for comparison with the S&P 500....

Is Core Laboratories, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Core Laboratories, Inc. has changed from mildly bearish to mildly bullish. The weekly and monthly MACD indicators are both mildly bullish, supporting the positive shift in trend. Bollinger Bands also indicate a bullish stance on both time frames. However, daily moving averages remain mildly bearish, which suggests some short-term caution. The KST shows a bullish weekly signal but is bearish monthly, while the Dow Theory indicates a mildly bullish trend in both weekly and monthly perspectives. Overall, the technical stance is mildly bullish, driven primarily by the MACD and Bollinger Bands. Multi-period return data is not available for comparison with the S&P 500....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.86%

EBIT Growth (5y)

-7.79%

EBIT to Interest (avg)

3.66

Debt to EBITDA (avg)

2.50

Net Debt to Equity (avg)

0.45

Sales to Capital Employed (avg)

1.29

Tax Ratio

32.98%

Dividend Payout Ratio

5.97%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

12.62%

ROE (avg)

12.43%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.08

EV to EBIT

13.94

EV to EBITDA

10.54

EV to Capital Employed

1.74

EV to Sales

1.24

PEG Ratio

Dividend Yield

70.95%

ROCE (Latest)

12.51%

ROE (Latest)

10.05%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Bearish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 49 Schemes (56.68%)

Foreign Institutions

Held by 78 Foreign Institutions (9.38%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.34% vs -4.33% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 10,600.00% vs -98.67% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "130.20",
          "val2": "123.60",
          "chgp": "5.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.00",
          "val2": "10.50",
          "chgp": "52.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "2.60",
          "chgp": "3.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.70",
          "val2": "0.10",
          "chgp": "10,600.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.70%",
          "val2": "54.60%",
          "chgp": "4.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.75% vs 4.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.97% vs 87.82% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "523.80",
          "val2": "509.80",
          "chgp": "2.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "63.60",
          "val2": "69.60",
          "chgp": "-8.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.40",
          "val2": "13.40",
          "chgp": "-7.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.60",
          "val2": "-1.70",
          "chgp": "488.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.20",
          "val2": "37.00",
          "chgp": "-12.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.80%",
          "val2": "105.50%",
          "chgp": "-1.27%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

130.20

123.60

5.34%

Operating Profit (PBDIT) excl Other Income

16.00

10.50

52.38%

Interest

2.70

2.60

3.85%

Exceptional Items

2.60

0.00

Consolidate Net Profit

10.70

0.10

10,600.00%

Operating Profit Margin (Excl OI)

94.70%

54.60%

4.01%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.34% vs -4.33% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 10,600.00% vs -98.67% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

523.80

509.80

2.75%

Operating Profit (PBDIT) excl Other Income

63.60

69.60

-8.62%

Interest

12.40

13.40

-7.46%

Exceptional Items

6.60

-1.70

488.24%

Consolidate Net Profit

32.20

37.00

-12.97%

Operating Profit Margin (Excl OI)

92.80%

105.50%

-1.27%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 2.75% vs 4.10% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -12.97% vs 87.82% in Dec 2023

All Annual Results

Company CV

About Core Laboratories, Inc.

Core Laboratories, Inc.

Oil

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Company Coordinates

Company Details

Tower a, Level 9, Strawinskylaan 913 , AMSTERDAM None : 1077 XX

Tel: 31 24 203191

https://www.corelab.com/

Registrar Details

Core Laboratories, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Core Laboratories, Inc.?

Watch in Real-Time

What does Core Laboratories, Inc. do?

Who are in the management team of Core Laboratories, Inc.?

Is Core Laboratories, Inc. technically bullish or bearish?

Is Core Laboratories, Inc. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

Positive results in Jun 25

With ROCE of 12.51%, it has a very expensive valuation with a 1.74 Enterprise value to Capital Employed

High Institutional Holdings at 100%

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Core Laboratories, Inc. overvalued or undervalued?

Is Core Laboratories, Inc. technically bullish or bearish?

Is Core Laboratories, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About Core Laboratories, Inc.

Company Coordinates